Women Now Make Up Nearly Two Thirds of Puori's Creatine Buyers, New Customer Data Shows

Puori reported U.S. creatine unit sales rose 127% year over year in June-August 2026, while creatine became its second-most purchased product, up from fifth. Women represented 63% of customers purchasing Creatine+ in Q2, and the purchase rate among customers aged 65+ rose to 27% from 7% in Q1 2025. The data indicates broadening consumer demand for creatine beyond its traditional young male fitness market, although the figures are company-reported survey and direct-store sales data.

Analysis

This is a category-expansion signal rather than a meaningful Shopify fundamental catalyst. Creatine’s addressable market is shifting from performance nutrition toward healthy aging and women’s wellness, where purchase frequency, trust and format matter more than bulk-price positioning. That favors premium, clinically positioned brands and retailers with subscription/first-party customer-data capabilities; it is incrementally negative for commodity powder suppliers and legacy sports-nutrition brands whose packaging, messaging and retail placement remain male-athlete centric.

The stated growth is from a single brand’s direct channel and customer survey, so it cannot establish category-wide demand elasticity or durable repeat rates. The key 1-3 month validation is whether Amazon bestseller rank, Google search trends, Circana/Nielsen retail data, and broader branded players show the same demographic mix; without this, the likely outcome is a marketing-led share gain rather than a new supplement cycle. Over 6-18 months, FDA scrutiny of healthy-aging claims or adverse-event headlines would disproportionately damage premium brands relying on trust-based pricing, while commodity capacity expansion could compress gross margins if creatine becomes a mass-market staple.

For SHOP, the relevant mechanism is only indirect: higher direct-to-consumer supplement acquisition and subscription activity may modestly support merchant-services volume, but Puori’s disclosed store sales are immaterial against Shopify’s GMV base. There is no standalone SHOP trade signal. The contrarian view is that the market may over-extrapolate demographic adoption into pricing power: an ingredient with limited product differentiation typically sees customer acquisition costs rise and price competition intensify once larger CPG and mass retailers target the same cohort.

Key Decisions for Investors

• No directional SHOP position on this release; treat it as a low-signal DTC merchant datapoint. Reassess only if multiple scaled Shopify wellness merchants demonstrate sustained subscription/reorder growth in quarterly disclosures or Shopify reports an identifiable health-and-wellness GMV acceleration.
• Create a 1-3 month watchlist for premium nutrition exposure rather than buying commodity supplement proxies: require independent evidence of category sell-through and repeat purchase before underwriting revenue upside. Key confirmation metrics are Amazon rank durability after promotions, retail scanner data, and gross-margin resilience.
• If public branded nutrition companies begin attributing growth to creatine-led healthy-aging demand, favor a pair framework of long differentiated, clinically validated brand exposure versus short commodity/private-label-heavy nutrition exposure; do not initiate until SKU-level sales mix and margin data identify the relevant listed names.
• Thesis falsifier for the category watch: broad retail creatine unit growth decelerates materially while promotional intensity rises, or regulators challenge aging/cognition-related marketing claims. Either outcome would indicate demand is being pulled forward or monetized through discounting rather than expanding profit pools.